Impact of RANK signalling on survival and chemotherapy response in osteosarcoma
Zsuzsanna Bagó-Horváth(Comprehensive Cancer Center Vienna), Irene Sulzbacher(Medical University of Vienna), Katharina Schmid(Medical University of Vienna), Katalin Nagy-Bojarszky(Medical University of Vienna), Philipp T. Funovics(Medical University of Vienna), Fabian Rössler(Comprehensive Cancer Center Vienna)
Cited by 40
Related Papers
Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice
|Science|2018|422
Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone
|Annals of Oncology|2013|403
Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial
|Nature Medicine|2022|395
Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure–activity relationship
|Biochemical Pharmacology|2005|303